Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €48.15 EUR
Change Today +0.78 / 1.64%
Volume 0.0
BHM On Other Exchanges
SIX Swiss Ex
As of 1:36 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

bachem holding ag-reg b (BHM) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/12/15 - €51.78
52 Week Low
10/14/14 - €35.25
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BACHEM HOLDING AG-REG B (BHM)

Related News

No related news articles were found.

bachem holding ag-reg b (BHM) Related Businessweek News

No Related Businessweek News Found

bachem holding ag-reg b (BHM) Details

Bachem Holding AG, a technology-based biochemicals company, provides services to the pharmaceutical and biotechnology industries primarily in Europe and North America. It develops and manufactures peptide and small molecule active pharmaceutical ingredients (APIs), as well as biochemicals for research purposes. The company offers research products, which include catalog products comprising amino acid derivatives, peptides, and other biochemicals in various packaging sizes for peptide research, small scale peptide synthesis, or other research area; custom synthesis service for peptides and amino acids; sterile peptides under the Clinalfa brand; and glycosylated peptides to improve drug properties. It also provides API products comprising generic APIs used in the fields of cancer, diabetes, obesity, fertility, and others; and new chemical entities. In addition, the company offers customer support services, such as formulation development; sterile tox-vials; compatibility studies; stress tests; post-release stability studies; chemistry, manufacturing, and control documentation for investigational medicinal product dossier and investigational new drug services; and other services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.

821 Employees
Last Reported Date: 08/28/15
Founded in 1971

bachem holding ag-reg b (BHM) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: SFr.396.0K
Compensation as of Fiscal Year 2014.

bachem holding ag-reg b (BHM) Key Developments

Bachem Holding AG Announces Earnings Results for the Year 2014

Bachem Holding AG announced earnings results for the year 2014. For the year, sales were CHF 183.9 million against CHF 170.7 million a year ago. EBITDA was CHF 55.1 million against CHF 47.4 million a year ago. EBIT was CHF 35.9 million against CHF 29.5 million a year ago. Net income was CHF 29.1 million against CHF 23.6 million a year ago. Earnings per share were CHF 2.15 against CHF 1.75 a year ago. Cash flow from operating activities was CHF 47.2 million against CHF 49.2 million a year ago. Return on equity was 8.5% against 7.0 % a year ago.

Bachem Holding AG Presents at BIO-Europe Spring 2015, Mar-09-2015

Bachem Holding AG Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.

Bachem Holding AG Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

Bachem Holding AG Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BHM:GR €48.15 EUR +0.78

BHM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BHM.
View Industry Companies

Industry Analysis


Industry Average

Valuation BHM Industry Range
Price/Earnings 24.9x
Price/Sales 3.9x
Price/Book 2.1x
Price/Cash Flow 12.5x
TEV/Sales 1.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BACHEM HOLDING AG-REG B, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at